Junshi Biosciences Announces 2023 Full Year Financial
SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading...
Source: globenewswire.com
Rxilient Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rxilient Biotech. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rxilient Biotech Today - Breaking & Trending Today
Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates
SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading…
Source: financialpost.com
Junshi Biosciences Announces 2023 Interim Financial Results and Provides Corporate Updates
SHANGHAI, China, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leadi...
Source: businessinsider.com
Drug Maker Junshi Seeks Swiss Cure For Cash Woes - BeiGene (NASDAQ:BGNE), Coherus BioSciences (NASDAQ:CHRS)
Key Takeaways: Junshi Biosciences reported dismal results in the first quarter, with operating income plunging nearly 60% and its net loss expanding by 37% Hopes of a big revenue boost from an oral Covid drug have been dashed, and the company may not recoup its investment in the short term By Molly Wen
Source: benzinga.com
Junshi Biosciences, Rxilient Biotech Partner Develop Toripalimab In Southeast Asia
The two parties plan to collaborate to introduce more high-quality innovative drugs into Southeast Asian markets to achieve joint and long-term development.
Source: contractpharma.com